Drug Type Small molecule drug |
Synonyms Dolocam Plus |
Target |
Action inhibitors |
Mechanism CA1 inhibitors(Carbonic anhydrase I inhibitors), COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC11H15NO5 |
InChIKeyGNXFOGHNGIVQEH-UHFFFAOYSA-N |
CAS Registry532-03-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Arthritis | Brazil | - | |
Bursitis | Brazil | - | |
Contracture | Brazil | - | |
Muscle injury | Brazil | - | |
Tendinopathy | Brazil | - | |
Torticollis | Brazil | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breakthrough Pain | NDA/BLA | - | 30 Nov 2013 | |
Low Back Pain | NDA/BLA | - | 30 Nov 2013 |